These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33799468)
1. Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study. di Leo N; Moscato S; Borso' M; Sestito S; Polini B; Bandini L; Grillone A; Battaglini M; Saba A; Mattii L; Ciofani G; Chiellini G Molecules; 2021 Mar; 26(6):. PubMed ID: 33799468 [TBL] [Abstract][Full Text] [Related]
2. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083 [TBL] [Abstract][Full Text] [Related]
3. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection. Laurino A; Gencarelli M; Raimondi L Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926 [TBL] [Abstract][Full Text] [Related]
4. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions. Hoefig CS; Zucchi R; Köhrle J Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974 [TBL] [Abstract][Full Text] [Related]
5. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926 [No Abstract] [Full Text] [Related]
6. Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1). Gencarelli M; Lodovici M; Bellusci L; Raimondi L; Laurino A Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269859 [TBL] [Abstract][Full Text] [Related]
7. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes. Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446 [TBL] [Abstract][Full Text] [Related]
8. Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls. Lorenzini L; Ghelardoni S; Saba A; Sacripanti G; Chiellini G; Zucchi R Thyroid; 2017 Oct; 27(10):1323-1331. PubMed ID: 28859548 [TBL] [Abstract][Full Text] [Related]
9. Exogenous 3-Iodothyronamine (T Bandini L; Sacripanti G; Borsò M; Tartaria M; Fogliaro MP; Giannini G; Carnicelli V; Figuccia ME; Verlotta S; De Antoni F; Zucchi R; Ghelardoni S Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143389 [TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399 [TBL] [Abstract][Full Text] [Related]
12. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism. Lehmphul I; Hoefig CS; Köhrle J Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352 [TBL] [Abstract][Full Text] [Related]
13. Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6. Bellusci L; Runfola M; Carnicelli V; Sestito S; Fulceri F; Santucci F; Lenzi P; Fornai F; Rapposelli S; Origlia N; Zucchi R; Chiellini G Molecules; 2020 Feb; 25(5):. PubMed ID: 32110992 [TBL] [Abstract][Full Text] [Related]
14. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? Rutigliano G; Bandini L; Sestito S; Chiellini G Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490 [TBL] [Abstract][Full Text] [Related]
15. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes. Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620 [TBL] [Abstract][Full Text] [Related]
16. Characterization of 3-iodothyronamine in vitro dynamics by mathematical modeling. Orsi G; Ghelardoni S; Saba A; Zucchi R; Vozzi G Cell Biochem Biophys; 2014 Jan; 68(1):37-47. PubMed ID: 23723010 [TBL] [Abstract][Full Text] [Related]
17. Determination of 3-iodothyronamine (3-T Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577 [TBL] [Abstract][Full Text] [Related]